Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the efficacy and safety of radium-223 dichloride in subjects with HER2 negative, hormone receptor positive breast cancer with bone metastases treated with hormonal treatment background therapy.
Inclusion criteria
- HER2 negative hormone receptor positive metastatic breast cancer with bone metastases treated with standard of care hormonal treatment